Approximately 10% of patients with blood cancers who were vaccinated against COVID-19 reported a breakthrough infection during the original Omicron surge. Those with no detectable antibodies or low antibody levels were more likely to be hospitalized for COVID-19 infection.
Dr. Lee Greenberger from the Leukemia & Lymphoma Society (LLS) and colleagues presented the results at the American Society for Hematology (ASH) Annual Meeting in 2022.
Read the full article on CLL Society's website at: [ Ссылка ]
__________________________________________________________________________________________
CLL Society Website: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
